{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Mibefradil_Dihydrochloride",
  "nciThesaurus": {
    "casRegistry": "116666-63-8",
    "chebiId": "",
    "chemicalFormula": "C29H38FN3O3.2HCl",
    "definition": "",
    "fdaUniiCode": "842TUP3PQ8",
    "identifier": "C87687",
    "preferredName": "Mibefradil Dihydrochloride",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C333"
    ],
    "synonyms": [
      "(1S,2S)-(2-((3-(2-Benzimidazolyl)Propyl)Methylamino)Ethyl)-6-Fluoro-1,2,3,4-Tetrahydro-1-Isopropyl-2-Naphthyl Methoxyacetate, Dihydrochloride",
      "Acetic Acid, Methoxy-, 2-(2-((3-(1H-Benzimidazol-2-yl)Propyl)Methylamino)Ethyl)-6-Fluoro-1,2,3,4-Tetrahydro-1-(1-Methylethyl)-2-Naphthalenyl Ester, Dihydrochloride, (1S-cis)-",
      "MIBEFRADIL DIHYDROCHLORIDE",
      "Mibefradil Dihydrochloride",
      "RO 40-5967/001"
    ]
  }
}